Jubilant Pharmova Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Jubilant Pharmova. An average target of ₹1259
Source: S&P Global Market Intelligence
Jubilant Pharmova Share analysis
Jubilant Pharmova price forecast by 2 analysts
Upside of33.71%
High
₹1450
Target
₹1259.00
Low
₹1068
Jubilant Pharmova target price ₹1259, a slight upside of 33.71% compared to current price of ₹968.4. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Jubilant Pharmova revenue growth forecast
Expected growth rate Q1, FY2027:42.00%
Forecast
Actual
Including amortisation and stock based compensations
Jubilant Pharmova EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Jubilant Pharmova Performance
Day's Low
Day's High
₹935.15Day's Price Range₹97552 Week's Low
52 Week's High
₹532.1552-Week Price Range₹1,309.9
| Returns % | |
| 1 Month Return | -11.3 % |
| 3 Month Return | -20.44 % |
| 1 Year Return | + 64.77 % |
| Market Stats | |
| Previous Close | ₹941.60 |
| Open | ₹968.50 |
| Volume | 5.64L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹14,999.69Cr |
Jubilant Pharmova Key Statistics
| P/E Ratio | 25.15 |
| PEG Ratio | 0.63 |
| Market Cap | ₹14,999.69 Cr |
| P/B Ratio | 3.81 |
| EPS | 4.6 |
| Dividend Yield | 0.88 |
| Sector | Pharmaceuticals |
| ROE | 1.32 |
Jubilant Pharmova Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹14,999.69 Cr | 15.92% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| BUY | ₹27,479.01 Cr | 108.1% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| NA | ₹5,799.20 Cr | -1.51% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹14,798.11 Cr | 44.74% | 0.68 | ₹218 Cr | ₹1,296 Cr | |
| BUY | ₹25,422.62 Cr | 173.75% | 0.55 | ₹258 Cr | ₹1,375 Cr |
About Jubilant Pharmova
Share Price: ₹968.40 per share as on 20 Jan, 2025 10:57 AM
Market Capitalisation: ₹14,999.69Cr as of today
Revenue: ₹1,742.20Cr as on September 2024 (Q3 24)
Net Profit: ₹102.50Cr as on September 2024 (Q3 24)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
| Organisation | Jubilant Pharmova |
| Headquarters | Noida |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Jubilant Pharmova Ltd
Jubilant Pharmova Faces USFDA Observations Impact - 17 Jan, 2025
Jubilant Pharmova's subsidiary, Jubilant Cadista Pharmaceuticals, received five observations from the USFDA during an inspection, leading to a 2% drop in shares. The facility has ceased manufacturing operations since April 2024.
Insights on Jubilant Pharmova Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, JUBLPHARMA stock has moved up by 27.4%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, JUBLPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 2.25% to 3.06% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 41.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.68% of holdings in Sep 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 19.49% to 17.94% in Sep 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.18% to 25.17% in Sep 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.14K Cr → 1.77K Cr (in ₹), with an average decrease of 17.2% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 482.1 Cr → 102.8 Cr (in ₹), with an average decrease of 78.7% per quarter
Jubilant Pharmova Financials
Index Inclusions
Jubilant Pharmova Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.68% | 0.00 | |
| Foreign Institutions | 17.94% | ||
| Mutual Funds | 3.06% | 35.81 | |
| Retail Investors | 25.17% | ||
| Others | 3.16% | 31.44 |
Jubilant Pharmova Key Indicators
Jubilant Pharmova Valuation
Jubilant Pharmova in the last 5 years
Lowest (-195.50x)
December 29, 2023
Today (25.15x)
January 17, 2025
Industry (54.95x)
January 17, 2025
Highest (257.22x)
February 16, 2024
Jubilant Pharmova Earnings and Dividends
Jubilant Pharmova Ltd Earnings Results
Jubilant Pharmova Ltd’s net profit jumped 64.48% since last year same period to ₹102.80Cr in the Q2 2024-2025. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -78.68% fall in its net profits since last 3-months.
Read More about Earnings ResultsJubilant Pharmova Ltd Dividends May,2024
In the quarter ending March 2024, Jubilant Pharmova Ltd has declared dividend of ₹5 - translating a dividend yield of 1.06%.
Read More about Dividends
Jubilant Pharmova Technicals Summary
Bearish
Neutral
Bullish
Jubilant Pharmova Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Jubilant Pharmova Ltd
Jubilant Pharmova Ltd share price today stands at ₹968.4, Open. ₹968.5 ; Previous Close. ₹941.6 ; High. ₹975 ; Low. ₹935.15 ; 52 Week High. ₹1309.9 ; 52 Week Low: ₹532.15.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Jubilant Pharmova Ltd shares.
Jubilant Pharmova Ltd is listed on NSE
Jubilant Pharmova Ltd is listed on BSE
- Today’s highest price of Jubilant Pharmova Ltd is ₹975.
- Today’s lowest price of Jubilant Pharmova Ltd is ₹935.15.
PE Ratio of Jubilant Pharmova Ltd is 25.15
PE ratio = Jubilant Pharmova Ltd Market price per share / Jubilant Pharmova Ltd Earnings per share
Today’s traded volume of Jubilant Pharmova Ltd(JUBLPHARMA) is 5.64L.
Today’s market capitalisation of Jubilant Pharmova Ltd(JUBLPHARMA) is ₹14999.69Cr.
| Jubilant Pharmova Ltd(JUBLPHARMA | Price |
|---|---|
52 Week High | ₹1309.9 |
52 Week Low | ₹532.15 |
Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹968.4. It is down -26.07% from its 52 Week High price of ₹1309.9
Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹968.4. It is up 81.98% from its 52 Week Low price of ₹532.15
| Jubilant Pharmova Ltd(JUBLPHARMA | Returns |
|---|---|
1 Day Returns | 26.8% |
1 Month Returns | -11.3% |
3 Month Returns | -20.44% |
1 Year Returns | 64.77% |